American Conference Institute’s 2nd Annual Forum on:Paragraph IV DisputesTuesday, December 06 to Wednesday, December 07, 2011
Hotel Nikko, San Francisco, CA
The must-attend event for litigators from brand name and generic companies to share insights into increasingly high-stakes and complicated Hatch-Waxman litigation With hundreds of billions of dollars at stake as blockbuster drugs go off patent in 2014, Hatch-Waxman litigation will only intensify as branded companies fight to delay generic entry and extend patent life through all means possible, and as generic companies fight amongst themselves for fewer opportunities to attain the prized 180-day exclusivity period. Constantly evolving case law including Therasense, Caraco v. Novo-Nordisk, and Plavix and legislative developments including long-awaited patent reform create more questions and will spawn more litigation as well. At American Conference Institute’s 2nd Annual West Coast edition of its acclaimed Paragraph IV Disputes conference, an experienced faculty of renowned litigators and judges will guide you through every stage of a Paragraph IV challenge to help you formulate the offensive moves and defensive plays for the next round in the no-holds barred fi ght for pharmaceutical product market share. Additionally, in the wake of major developments in pay-for-delay, learn what the Federal Trade Commission deems foul and fair in the settlement of Paragraph IV disputes in order to draft and structure a settlement that will receive FTC approval. At this in-depth strategy session on the nuances of PIV litigation, our West Coast delegates will gain the tools to advance a novel claim or defense to protect patents and market share based on the expertise of trial leading patent counsel from generic and branded companies – and the judges – who have experienced the intricacies of Hatch Waxman litigation first hand. Featuring an up-to-the-minute analysis of the latest game-changing case law developments regarding inequitable conduct, inducement of infringement and the standard of invalidity, this conference will give our attendees the tools and litigation strategies to help both brand name and generic companies protect market share and ultimately profits. In this costly and ruthless endgame, not a moment can be lost. Don’t delay- register now by calling 1-888-224-2480, faxing your registration form to 877-927-1563, or logging onto to www.AmericanConference.com/ParagraphIVSNF |
Brochure
![]() - click image for pdf - Dates: Tue, Dec 06, 2011 Wed, Dec 07, 2011 Location:
Accreditation:Hotel Nikko San Francisco, CA Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation. ACI certifies that the activity has been approved for CLE credit by the New York State Continuing Legal Education Board in the amount of 10.5 hours (1.0 hours of ethics). An additional 4.5 credit hours will apply to participation in Boot Camp A and 2.0 hours for participation in Master Class B. ACI certifies that this activity has been approved for CLE credit by the State Bar of California in the amount of 9.0 hours (1.0 hours of ethics). An additional 4.0 credit hours will apply to participation in Boot Camp A and 2.0 hours for participation in Master Class B.You are required to bring your state bar number to complete the appropriate state forms during the conference. CLE credits are processed in 4-8 weeks after a conference is held. ACI has a dedicated team which processes requests for state approval. Please note that event accreditation varies by state and ACI will make every effort to process your request.Questions about CLE credits for your state? Visit our online CLE Help Center at www.americanconference.com/CLE |
|

Browse C5 Companies









